Skip to main content
. Author manuscript; available in PMC: 2008 Apr 5.
Published in final edited form as: Regul Pept. 2006 Dec 28;140(1-2):12–20. doi: 10.1016/j.regpep.2006.11.020

Figure 4.

Figure 4

Effect of kallikrein infusion on (A) NADH oxidase activity, (B) MDA levels (C) relative p22phox mRNA levels, (D) superoxide formation. Values are expressed as mean ± SEM (n=6–7, *P<0.05 vs. MI & MI/TK+Icatibant).